Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy

INTRODUCTION: Immune checkpoint inhibitor-related pneumonitis (ICIP) is a potentially life threatening immune-related adverse event (irAE), especially in non-small cell lung cancer (NSCLC) patients. Currently, the potential for increased irAE in patients who receive radiotherapy is scarcely known, a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Oncol
Glavni autori: Barrón, Feliciano, Sánchez, Roberto, Arroyo-Hernández, Marisol, Blanco, Carolina, Zatarain-Barrón, Zyanya L., Catalán, Rodrigo, Ramos-Ramírez, Maritza, Cardona, Andrés F., Flores-Estrada, Diana, Arrieta, Oscar
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Oncology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7550759/
https://ncbi.nlm.nih.gov/pubmed/33117699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.570233
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items